These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6739008)

  • 1. [Therapeutic action of torfot in corneal opacities].
    Gorgiladze TU; Marmur RK; Nepomiashchaia VM; Kolesnichenko AM; Kuksa VD
    Oftalmol Zh; 1984; (1):6-8. PubMed ID: 6739008
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical observations on treatment of corneal opacities with ultrasound (author's transl)].
    Fang YS
    Zhonghua Yan Ke Za Zhi; 1980 Feb; 16(1):72-3. PubMed ID: 6788500
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effectiveness of ultrasonic therapy in corneal opacities].
    Tsok RM
    Vestn Oftalmol; 1966; 79(4):34-6. PubMed ID: 5981666
    [No Abstract]   [Full Text] [Related]  

  • 4. [Simultaneous ultrasonic therapy and electrophoresis in corneal opacity].
    Tsok RM
    Vestn Oftalmol; 1967; 80(2):70-1. PubMed ID: 5620347
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrolytic removal of recurrence of granular corneal dystrophy.
    Mashima Y; Kawashima M; Yamada M
    Eye (Lond); 2003 Nov; 17(8):975-81. PubMed ID: 14631404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Keratoplasty or corneal lens].
    von Haugwitz T
    Klin Monbl Augenheilkd; 1967; 150(1):80-3. PubMed ID: 5598226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Congenital corneal opacities: current problems in differential diagnosis and treatment strategy].
    Khvatova AV; Pleskova AV
    Vestn Oftalmol; 2002; 118(3):47-50. PubMed ID: 12226984
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effectiveness of using contact lenses in limited non-intensive corneal opacities].
    Skitsiuk NF; Golubenko IuE
    Oftalmol Zh; 1984; (2):88-91. PubMed ID: 6739024
    [No Abstract]   [Full Text] [Related]  

  • 9. [Curative effect of subconjunctival injections of various doses of torfot in corneal opacities].
    Bushmich DG; Golatska IaS
    Oftalmol Zh; 1972; 27(2):103-7. PubMed ID: 5028776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pemphigus vulgaris. Favorable action of corticotherapy associated with hyperbaric oxygen therapy].
    Hadida E; Sayag J; Bonerandi JJ; Vallette P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(5):522-3. PubMed ID: 5152895
    [No Abstract]   [Full Text] [Related]  

  • 11. Non-trachomatous corneal opacities in the Gambia--aetiology and visual burden.
    Bowman RJ; Faal H; Dolin P; Johnson GJ
    Eye (Lond); 2002 Jan; 16(1):27-32. PubMed ID: 11915876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dense subepithelial corneal haze after laser-assisted subepithelial keratectomy.
    Mirza MA; Qazi MA; Pepose JS
    J Cataract Refract Surg; 2004 Mar; 30(3):709-14. PubMed ID: 15050273
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microcryogenic therapy and pharmacotherapy of corneal opacities (preliminary communication) (author's transl)].
    Witusik W
    Klin Oczna; 1978 Aug; 48(8):411-2. PubMed ID: 703180
    [No Abstract]   [Full Text] [Related]  

  • 14. Recurrent subepithelial corneal opacities after excimer laser phototherapeutic keratectomy.
    Starr MB
    Cornea; 1999 Jan; 18(1):117-20. PubMed ID: 9894948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corneal tattooing to mask subsequent opacification after amniotic membrane grafting for stromal corneal ulcer.
    Lee JE; Jun JB; Choi HY; Oum BS; Lee JS
    Acta Ophthalmol Scand; 2006 Oct; 84(5):696-8. PubMed ID: 16965504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrolysis for corneal opacities in a young patient with superficial variant of granular corneal dystrophy (Reis-Bücklers corneal dystrophy).
    Kamoi M; Mashima Y; Kawashima M; Tsubota K
    Am J Ophthalmol; 2005 Jun; 139(6):1139-40. PubMed ID: 15953463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Deep corneal stroma opacities after contact lens wear].
    Kilp H; Konen W; Zschausch B; Lemmen K
    Fortschr Ophthalmol; 1982; 79(2):116-7. PubMed ID: 7184825
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase I/II evaluation of safety and efficacy of a matrix-targeted retroviral vector bearing a dominant negative cyclin G1 construct (Md-dnG1) as adjunctive intervention for superficial corneal opacity/corneal scarring.
    Song JC; McDonnell PJ; Gordon EM; Hall FL; Anderson WF
    Hum Gene Ther; 2003 Feb; 14(3):306-9. PubMed ID: 12675032
    [No Abstract]   [Full Text] [Related]  

  • 19. [Honey treatment of postherpetic opacities of the cornea].
    Mozherenkov VP
    Oftalmol Zh; 1984; (3):188. PubMed ID: 6483344
    [No Abstract]   [Full Text] [Related]  

  • 20. [Herpetic keratitis and corneal grafting].
    Adenis JP; Burillon C; Delbosc B; Pouliquen Y
    J Fr Ophtalmol; 1996; 19(12):814-6. PubMed ID: 9033907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.